+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Brain Cancer Drugs Market Research Reports

Brain Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

Brain Cancer - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
From
Anaplastic astrocytoma - Pipeline Insight, 2022 - Product Thumbnail Image

Anaplastic astrocytoma - Pipeline Insight, 2022

  • Clinical Trials
  • May 2022
  • 85 Pages
From
Oligodendroglioma - Pipeline Insight, 2022 - Product Thumbnail Image

Oligodendroglioma - Pipeline Insight, 2022

  • Clinical Trials
  • May 2022
  • 60 Pages
From
From
From
Glioblastoma - Pipeline Insight, 2022 - Product Thumbnail Image

Glioblastoma - Pipeline Insight, 2022

  • Clinical Trials
  • March 2022
  • 100 Pages
From
Thymoma - Pipeline Insight, 2022 - Product Thumbnail Image

Thymoma - Pipeline Insight, 2022

  • Clinical Trials
  • March 2022
  • 60 Pages
From
From
Global Afinitor Drug Market 2021-2027 - Product Thumbnail Image

Global Afinitor Drug Market 2021-2027

  • Report
  • January 2022
  • 85 Pages
From
From
Global Brain Tumor Therapeutics Market 2021-2025 - Product Thumbnail Image

Global Brain Tumor Therapeutics Market 2021-2025

  • Report
  • January 2022
  • 120 Pages
From
From
Loading Indicator

With low survival rates primary brain cancers such as glioblastoma multiforme (the most common and aggressive of malignant brain tumours) are among the deadliest forms of cancer. Drug development activity is therefore intense in this sector, with resulting business development opportunities. Reports in the Brain Cancer section enable you to explore various facets of the industry from a variety of expert viewpoints, including R&D (clinical trials, drug discovery, etc.), competitive landscape, supply and demand, regional markets, regional market analysis, and much more. Show Less Read more